Mediwound Ltd. buy Marianka
Start price
22.08.22
/
50%
€1.99
Target price
22.08.23
€4.00
Performance (%)
-7.04%
End price
04.09.22
€1.85
Summary
This prediction ended on 04.09.22 with a price of €1.85. With a performance of -7.04%, the BUY prediction for Mediwound Ltd. by Marianka closed slightly in the red. Marianka has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mediwound Ltd. | -2.260% | -2.260% | 83.069% |
| iShares Core DAX® | 3.178% | 0.980% | 15.331% |
| iShares Nasdaq 100 | 2.972% | 0.925% | 39.831% |
| iShares Nikkei 225® | 0.545% | -4.556% | 17.661% |
| iShares S&P 500 | 2.367% | 0.833% | 30.000% |
According to Marianka what are the pros and cons of Mediwound Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
Capable Management
Good culture
Leading role in innovation
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Top 10 in its market
Known brand
Future proof or reliable business model
Standard Investments for future growth
Cons
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
High risks in the balance sheet
ROE lower than 10% per year
High challenges to pay loans and raise capital
high free float
High risks for its business
Significant cyclical dependencies